These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1580062)

  • 1. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
    Burnouf-Radosevich M; Burnouf T
    Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of factor VIII/von Willebrand factor from human plasma on immobilized lentil lectin.
    Zhou FL; Burnouf-Radosevich M; Burnouf T
    Protein Expr Purif; 1994 Apr; 5(2):138-43. PubMed ID: 8054845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition.
    Sixma JJ; Sakariassen KS; Beeser-Visser NH; Ottenhof-Rovers M; Bolhuis PA
    Blood; 1984 Jan; 63(1):128-39. PubMed ID: 6418228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
    Perret BA; Furlan M; Beck EA
    Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between bleeding time and platelet adherence to artery subendothelium.
    Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
    Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor.
    Colling ME; Friedman KD; Dzik WH
    Clin Appl Thromb Hemost; 2019; 25():1076029619873976. PubMed ID: 31496264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography.
    Mori F; Nardini I; Rossi P; Nardini C; Farina C
    Vox Sang; 2008 Nov; 95(4):298-307. PubMed ID: 19138259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
    Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor characterization of a severe dry-heat treated factor VIII concentrate, AHF (high purity).
    Oates A; Polmear E; Herrington R; Farrugia A; Sykes S; Raines G; Aumann H; Street A
    Thromb Res; 1992 Feb; 65(3):389-99. PubMed ID: 1631803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
    Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of multimeric structure and ristocetin-induced binding to platelets of von Willebrand factor present in cryoprecipitate and different factor VIII concentrates.
    López-Fernández MF; López-Berges C; Corral M; García-Talavera JR; López Borrasca A; Batlle J
    Vox Sang; 1987; 52(1-2):15-9. PubMed ID: 3111088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of a therapeutic concentrate of factor VIII/vWf prepared in a closed system].
    Mazurier C; Maillard J; Parquet-Gernez A; Goudemand M
    Rev Fr Transfus Immunohematol; 1982 Feb; 25(1):25-43. PubMed ID: 6803339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly purified factor VIII:c concentrate prepared from cryoprecipitate by ion-exchange chromatography.
    Burnouf T; Burnouf-Radosevich M; Huart JJ; Goudemand M
    Vox Sang; 1991; 60(1):8-15. PubMed ID: 1905084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study of a triple-secured von Willebrand factor concentrate.
    Mazurier C; Poulle M; Samor B; Hilbert L; Chtourou S
    Vox Sang; 2004 Feb; 86(2):100-4. PubMed ID: 15023178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.